Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder [Phase 1]
Phase 1 study evaluating the potential drug interaction between valproic acid and paliperidone extended-release in adults with schizophrenia…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: Ketamine Challenge Study With JNJ-40411813 [Phase 1]
Phase 1 ketamine challenge study of JNJ-40411813 by Johnson & Johnson Pharmaceutical Research & Development has completed. The trial explore…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)
An observational study assessing outcomes in schizophrenia patients treated with the long-acting injectable risperidone (RISPERDAL CONSTA) h…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Molecular Genetics of Schizophrenia
A completed clinical trial investigating the molecular genetics of schizophrenia conducted by Endeavor Health.
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants [Phase 4]
This document reports the results of a Phase 4 study evaluating Paliperidone's effect on subjective well-being and drug attitude in individu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating safety, efficacy, and tolerability of Paliperidone Extended-Release in adults with schizophrenia; the stud…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia [Phase 2]
This clinical trial update reports on a Phase 2 efficacy and safety study of three fixed doses of JNJ-37822681 in schizophrenia, sponsored b…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Association of Amisulpride Response in Schizophrenia With Brain Image [Phase 4]
A Phase 4 clinical trial update examining the association between brain imaging findings and response to amisulpride in schizophrenia and sc…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) [Phase 4]
Phase 4 TEOSS trial for early onset schizophrenia spectrum disorders has completed; results were posted in March 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Study Evaluating Vabicaserin in Subjects With Schizophrenia [Phase 2]
Pfizer completed a Phase 2 clinical trial evaluating vabicaserin in schizophrenia, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia [Phase 2]
Phase 2 pharmacokinetics study evaluating safety and tolerability of JNJ-37822681 in adults with stable schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Health Promotion and Fitness for Younger and Older Adults With SMI [NA]
A completed clinical trial update evaluating health promotion and fitness interventions for younger and older adults with serious mental ill…
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: A Study to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg [Phase 1]
A Phase 1 pharmacokinetic comparison of DWCZP 100 mg and Clozaril (clozapine) 100 mg in schizophrenia has been completed and results are pos…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Effects of Antipsychotic Medications on Energy Intake and Expenditure
A completed clinical trial evaluated the effects of antipsychotic medications on energy intake and energy expenditure in people with schizop…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Janssen - Glucose Regulation/Risp/Olanz [NA]
A Janssen-sponsored study evaluating glucose regulation in schizophrenia patients treated with risperidone or olanzapine has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Pfizer/IVGTT/Ziprasidone/Olanzapine [NA]
This clinical trial update reports completion of a study involving ziprasidone and olanzapine in schizophrenia and type 2 diabetes mellitus.…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder [Phase 4]
This Phase 4 trial evaluated the efficacy and safety of long-acting injectable risperidone compared with oral risperidone in adults with sch…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia [Phase 1, Phase 2]
Clinical trial update reporting results from Phase 1 and Phase 2 evaluating targeted cognitive training for neurological deficits in people …
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Paliperidone Palmitate Flexible Dosing in Schizophrenia [Phase 3]
A Phase 3 study evaluating flexible dosing of paliperidone palmitate for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants [Phase 4]
Phase 4 study assessing paliperidone extended-release for schizophrenia has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia [Phase 4]
This Phase 4 clinical trial reports on different Paliperidone Extended-Release dosing regimens and the clinical response in adults with acut…
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER [Phase 4]
A Phase 4 study assessing early prediction of clinical response to paliperidone ER in patients with schizophrenia (and schizoaffective disor…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment [Phase 4]
Phase 4 study evaluating the efficacy and safety of long-acting risperidone in adults with schizophrenia or schizoaffective disorder receivi…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Cognitive Remediation Therapy and Schizophrenia [NA]
A completed clinical trial evaluating cognitive remediation therapy for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism- [Phase 4]
Phase 4 clinical trial evaluating the effects of aripiprazole on glucose metabolism in patients with schizophrenia; results have been posted…